The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
VanEck Biotech ETF BBH
Morningstar’s Analysis BBH
Will BBH outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 67.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Amgen Inc | 15.12 | 63.6 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 9.47 | 39.8 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 7.60 | 32.0 Mil | Healthcare |
Gilead Sciences Inc | 7.55 | 31.7 Mil | Healthcare |
Moderna Inc | 5.87 | 24.7 Mil | Healthcare |
IQVIA Holdings Inc | 4.76 | 20.0 Mil | Healthcare |
Biogen Inc | 4.62 | 19.4 Mil | Healthcare |
argenx SE ADR | 4.50 | 18.9 Mil | Healthcare |
Illumina Inc | 4.24 | 17.8 Mil | Healthcare |
Icon PLC | 4.18 | 17.6 Mil | Healthcare |